CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced the appointment of Nancy J. Wysenski as Executive Vice President and Chief Commercial Officer. Ms. Wysenski has more than 30 years of experience in building commercial operations and in developing and implementing sales and marketing activities for major pharmaceutical products. Ms. Wysenski will serve as a member of Vertex’s executive team, reporting directly to the company’s Chairman, President and Chief Executive Officer, Matthew Emmens.
